i.5Summary
Acute and repeated dose toxicity studies indicate that MMT is absorbed via dermal, oral and respiratory routes. Disposition studies in animals indicate that the liver, kidney, brain, and lung are the primary sites of Mn accumulation following oral or dermal exposure to MMT. Manganese also accumulated in the pancreas, sublingual gland, thyroid, prostate, muscle, duodenum, urinary bladder, heart, abdominal fat and blood, but to a lesser extent. Inhalation exposure of rats and monkeys to MMT combustion products resulted in the accumulation of Mn in the brain, liver and lung. The finding in rats that less than 2% of pulmonary Mn resulting from subcutaneous exposure to MMT was extractable with heptane, suggests the presence of metabolites as opposed to MMT.
Studies investigating the biotransformation of MMT in vitro indicate the liver is the predominant site of MMT metabolism, followed by the lung, kidney and brain. As the metabolism of MMT in lung and liver microsomes in vitro is inhibited by carbon monoxide and N-decylimidazole, it is likely the cytochrome P-450 monoxygenase enzyme is responsible for the metabolism of MMT in rats. MMT and its metabolites are predominantly excreted in the urine and faeces of rats. The most abundant MMT metabolite was determined to be CMT followed by HMT.
j)Toxicity of MMT j.1Acute toxicity
Acute lethality studies are summarised in Table 12.
The major acute toxic effects of MMT include damage to the lungs by all routes, kidney, liver and spleen effects, tremors, convulsions, dyspnea and weakness.
Table 12. Summary of MMT acute lethality studies -
Route
|
Species
|
Result
|
Reference
|
Inhalation
|
Rat
|
LC50 (4hr) > 2 mg/m3
|
Moore et al., 1975a
|
|
Rat
|
LC50 (1hr) = 247 mg/m3
|
Ethyl Corporation, 1976h; Hinderer, 1979
|
|
Rat
|
LC50 (4hr) = 76 mg/m3
|
Ethyl Corporation, 1976h; Hinderer, 1979
|
|
Rat
|
LC50 (1hr) > 19.8 g/m3 (approx.)*
|
Ethyl Corporation, 1976a
|
|
Rat
|
LC50 (1hr) = 220 mg/m3
|
Witherup et al, Unknown date b
|
Oral
|
Rat (f)a
|
LD50 = 22.9 mg/kg bw
|
Witherup and Larson, 1965
|
|
Rat (f)b
|
LD50 = 16.8 mg/kg bw
|
Witherup and Larson, 1965
|
|
Rat (m)a
|
LD50 = 38.5 mg/kg bw
|
Witherup and Larson, 1965
|
|
Rat (m)b
|
LD50 = 23.7 mg/kg bw
|
Witherup and Larson, 1965
|
|
Rat (m)
|
LD50 = 175 mg/kg bw**
|
Witherup and Roell, 1965
|
|
Rat (f)
|
LD50 = 89 mg/kg bw**
|
Witherup and Roell, 1965
|
|
Rat
|
LD50 = 58 mg/kg bw
|
Hysell et al., 1974; Moore et al., 1975a
|
|
Rat
|
LD50 = 58 mg/kg bw
|
Ethyl Corporation, 1975a; Hinderer, 1979
|
|
Rat
|
LD50 = 175 mg/kg bw*
|
Ethyl Corporation, 1976b
|
|
Rat
|
LD50 = 50 mg/kg bw
|
Hanzlik et al., 1980a
|
|
Rata
|
LD50 = 23-176 mg/kg bw
|
Witherup et al., Unknown date b
|
|
Ratb
|
LD50 = 9->80 mg/kg bw
|
Witherup et al., Unknown date b
|
|
Mouse
|
LD50 = 230 mg/kg bw
|
Ethyl Corporation, 1977c; Hinderer, 1979
|
|
Mouse (f)
|
LD50 = 60 mg/kg bw
|
Majima, 1985
|
-
Table 12. Summary of MMT acute lethality studies (cont.)
|
Route
|
Species
|
Result
|
Reference
|
|
Mouse (m)
|
LD50 = 34 mg/kg bw
|
Majima, 1985
|
|
Mouse
|
LD50 = 352 mg/kg bw
|
Witherup et al., Unknown date b
|
|
Guinea pig (f)
|
LD50 = 905 mg/kg bw
|
Witherup et al., Unknown date b
|
|
Rabbit (f)
|
LD50 = 95 mg/kg bw
|
Witherup et al., Unknown date b
|
Dermal
|
Rabbit
|
LD50 (24 hrs) = 1350 mg/kg bw**
|
Witherup and Roell, 1965
|
|
Rabbit
|
LD50 (24 hrs) = 140 mg/kg bw
|
Ethyl Corporation, 1975b; Hinderer, 1979
|
|
Rabbit
|
LD50 (24 hrs) > 2000 mg/kg bw*
|
Ethyl Corporation, 1976c
|
|
Rabbit
|
LD50 (24 hrs) = 196.7 mg/kg bw
|
Ethyl Corporation, 1976e; Hinderer, 1979
|
|
Rabbit
|
LD50 (24 hrs) = 420 mg/kg bw
|
Ethyl Corporation, 1976f; Hinderer, 1979
|
|
Rabbit
|
LD50 (24 hrs) = 795 mg/kg bw
|
Ethyl Corporation, 1976g; Hinderer, 1979
|
|
Rabbita
|
LD50 (6 hrs) = 665 mg/kg bw
|
Witherup et al., Unknown date b
|
|
Rabbitb
|
LD50 (24 hrs) = 135 mg/kg bw
|
Witherup et al., Unknown date b
|
Intraperitoneal
|
Rat
|
LD50 = 23 mg/kg bw
|
Hanzlik et al., 1980a
|
|
Rat
|
LD50 = 6 mg/kg bw
|
Hakkinen & Haschek, 1982
|
|
Rat
|
LD50 = 12.1 mg/kg bw
|
Cox et al., 1987
|
|
Rat
|
LD50 = 4 mg/kg bw
|
Verschoyle et al., 1993
|
|
Mouse
|
LD50 = 138 mg/kg bw
|
Hakkinen & Haschek, 1982
|
|
Mousec
|
LD50 = 152 mg/kg bw
|
Fishman et al., 1987
|
|
Moused
|
LD50 = 999 mg/kg bw
|
Fishman et al., 1987
|
|
Hamster
|
LD50 = 270 mg/kg bw
|
Hakkinen & Haschek, 1982
|
Subcutaneous
|
Rat
|
LD50 > 10 mg/kg bw
|
Clay & Morris, 1989
|
Intravenous
|
Rabbit
|
LD50 = 6.6 mg/kg bw
|
Witherup et al., Unknown date b
|
a = peanut oil vehicle m = male only
b = kerosene vehicle e = Wesson oil vehicle
c = propylene glycol vehicle f = female only
d = corn oil vehicle
* = product tested is 62% MMT in petroleum distillate
** = product tested is 10% MMT in kerosene
Oral LD50 values in rats range from 9 to 176 mg/kg bw MMT. The oral LD50 in rats for 62% MMT in petroleum distillate is 175 mg/kg bw and for 10% MMT in kerosene is 89-175 mg/kg bw.
The LC50 for the rat ranges from 220 to 247 mg/m3 for a 1 hour exposure and >2 to 76 mg/m3 for a 4 hour exposure. The LC50 for 62% MMT in petroleum distillate (1 hour exposure) is >19.8 g/m3.
Dermal (24 h) LD50 values for undiluted MMT in the rabbit range from 140 to 795 mg/kg bw. The dermal (24 h) LD50 for 10% MMT in kerosene is 1350 mg/kg bw and for 62% MMT in petroleum distillate is > 2000 mg/kg bw.
Share with your friends: |